Which drug description would be most likely to meet approval as a generic drug?

Which drug description would be most likely to meet approval as a generic drug?

• A. A drug with a different strength than brand-name
• B. A drug with a different dosage form
• C. A drug is not bioequivalent to the brand-name
• D. Generic drug is available in the same approved strengths and dosage as the brand-name drug

Answer: (D)

Generics must deliver the same active ingredient in the same way as the brand-name product, meaning they must have the same strength and the same dosage form, and they must be bioequivalent. This ensures that the generic and brand-name are interchangeable in terms of dose, delivery, and therapeutic effect. The description that a generic comes in the same approved strengths and dosage as the brand-name fits this requirement exactly, making it the pathway most likely to gain approval. The other options describe changes to strength, dosage form, or lack of bioequivalence, all of which would prevent generic approval because they would not guarantee the same exposure and therapeutic outcome.

Generics must deliver the same active ingredient in the same way as the brand-name product, meaning they must have the same strength and the same dosage form, and they must be bioequivalent. This ensures that the generic and brand-name are interchangeable in terms of dose, delivery, and therapeutic effect. The description that a generic comes in the same approved strengths and dosage as the brand-name fits this requirement exactly, making it the pathway most likely to gain approval. The other options describe changes to strength, dosage form, or lack of bioequivalence, all of which would prevent generic approval because they would not guarantee the same exposure and therapeutic outcome.